PSYCHO-EMOTIONAL DISORDERS AND MEDICAL PSYCHOLOGICAL APPROACH TO PATIENTS IN PARKINSON'S DISEASE (LITERATURE REVIEW)
Keywords:
Parkinson's disease, psychoemotional disorders, medical psychologyAbstract
Parkinson's disease (PD) is a common neurodegenerative disorder clinically characterized by three main symptoms: bradykinesia, resting tremor, and muscle rigidity. However, PD is a complex, heterogeneous disease with a wide spectrum of clinical manifestations. In addition to movement disorders, many non-motor clinical signs are characteristic of PK, and these non-motor signs appear much earlier than motor signs and significantly affect the patient's quality of life. Among these non-motor signs, psycho-emotional disorders form a separate group. One of the leading places among the researches conducted on PD is occupied by scientific works aimed at studying the factors that worsen the quality of life of patients. Taking into account the specific negative impact of PK on the patient's quality of life, the development of individual treatment measures for the disease remains a promising task. Accordingly, various psycho-emotional disorders (PEB), including emotional, cognitive, behavioral (povedenie) disorders, fatigue, sleep and endurance disorders, are now being studied separately. From this point of view, in this article, we analyzed various international research studies that investigated PEB in PD patients, and the results of our analysis are presented below.
References
Aarsland D, Marsh L, Schrag A. Neuropsychiatric symptoms in Parkinsons disease. Mov Disord. 2009; 24(15):2175–86. DOI: 10.1002/mds.22589.;
Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323:548–60.;
Chaudhuri KR, Healy DG, Schapira AH; National Institute for Clinical Excellence. Non-motor symptoms of Parkin¬son’s disease: diagnosis and management. Lancet Neurol 2006;5:235-245;
Gallanger DA, Lees AJ, Shrag A. What are the most important nonmotor symptoms in patients with Parkinsons disease and are we missing them? Mov Disord. 2010;15(15):2493–500. DOI: 10.1002/mds.23394.;
Holmuratova, B., Rashidova, N., Khalimova, K., Matmurodov, R., & Rakhmatullaeva, G. (2023). The role of BDNF in the clinical course of primary headaches. Cephalalgia Reports, 6, 25158163231190292.;
Holmuratova, B., Rashidova, N., Khalimova, K., & Khudayarova, S. (2024). The role of brain-derived neurotrophic factor during Parkinson's disease. Parkinsonism & Related Disorders, 122.;
Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015;386(9996):896-912;
Khudayarova, S., Rakhmatullayeva, G., & Holmuratova, B. (2024). Examination of cognitive function in Parkinson's disease patients with chronic kidney disease. Parkinsonism & Related Disorders, 122.;
Khudayarova, S., Rakhmatullayeva, G., & Holmuratova, B. (2024). Vascular remodeling in patients with CKD as a risk factor for the development of vascular Parkinsonism. Parkinsonism & Related Disorders, 122.;
Kim J, Kim M, Kwon do Y, Seo WK, Kim JH, Baik JS, et al. Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson’s disease. J Neurol 2013; 260:429-437;
Lang AE, Lozano AM. Parkinson’s disease. First of two parts. N Engl J Med 1998;339:1044-1053.; 2. Braak H, Braak E. Pathoanatomy of Parkinson’s disease. J Neurol 2000;247 Suppl 2:II3-II10;
Leroi I, David R, Robert PH. Apathy in Parkinsons disease. In: Psychiatry of in Parkinsons Disease. Edmeier KP, O’Brien JT, Taylor J- P, editors. Basel: Karger; 2012. P. 27–40. DOI: http://dx.doi.org/10.1159/000331524;
Levin OS. Bolezn' Parkinsona kak neiropsikhiatricheskoe zabolevanie. Rukovodstvo dlya vrachei po materialam II Natsional'nogo kongressa po bolezni Parkinsona i rasstroistvam dvizhenii [Parkinson's illness as neuropsychiatric disease. The management for doctors on materials II of the National congress due to illness Parkinson and to disorders of movements]. Illarioshkina SN, Levina OS, editors. Moscow: NTsN RAMN; 2011. P. 99–104.
Levy R, Dubois B. Apathy and functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex. 2006;16(7):916–28. DOI:http://dx.doi.org/10.1093/cercor/bhj043. Epub 2005 Oct 5.]
McLean, G., Lawrence, M., Simpson, R. et al. Mindfulness-based stress reduction in Parkinson’s disease: a systematic review. BMC Neurol 17, 92 (2017). https://doi.org/10.1186/s12883-017-0876-4;
Nodel' MR, Yakhno NN. Nervous and mental disorders of parkinson's disease. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2009;(2):3–8. (In Russ.)]. DOI:http://dx.doi.org/10.14412/2074-2711-2009-30;
Mulin E, Leone E, Dujardin K, et al. Diagnostic criteria for apathy in clinical practice. Int J Geriatr Psychiatry. 2011;26(2):158–65.DOI: 10.1002/gps.2508;
Pedersen KF, Larsen JP, Alves G, Aarsland D. Prevalence and clinical correlates of apathy in Parkinsons disease: a community-based study. Parkinsonism Relat Disord. 2009 May;15(4):295–9. DOI: 10.1016/j.parkreldis.2008.07.006.Epub 2008 Sep 17.
Pluck GC, Brown RG. Apathy in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2002;73(6):636–42. DOI: http://dx.doi.org/10.1136/jnnp.73.6.636.
Scaravilli T, Gasparoli E, Rinaldi F, et al. Health-related quality of life and sleep disorders in Parkinson's disease. Neurol Sci. 2003 Oct;24(3):209–10. DOI: http://dx.doi.org/10.1007/s10072-003-0134-y.;
Stacy M. Nonmotor symptoms in Parkinson’s disease. Int J Neurosci 2011;121 Suppl 2:9-17;
Voon V., Hassan K., Zurowski M. et al. Prevalence of repetitive and re- ward-seeking behaviors in Parkinson’s disease. Neurology. 2006; 67: 1254–1257. PMID: 16957130. DOI: 10.1212/01.wnl.0000238503.20816.13.
Weintraub D., Koester J., Potenza M.N. et al. Impulsive control disorders in Parkinson’s disease: a cross-sectional study of 3090 patients. Arch. Neurol. 2010; 67: 589–595. PMID: 20457959. DOI: 10.1001/archneurol.2010.65.
